Key terms

About SDGR

Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.

Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SDGR news

Apr 04 9:10am ET Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Schrodinger (SDGR) Apr 04 8:20am ET Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA) Feb 29 7:47am ET Piper Sandler Keeps Their Buy Rating on Schrodinger (SDGR) Feb 29 7:44am ET Schrodinger price target lowered to $50 from $60 at Piper Sandler Feb 29 7:29am ET Buy Rating Affirmed for Schrodinger Amidst Robust Software Business and Promising Clinical Milestones Feb 29 6:52am ET Schrodinger price target lowered to $33 from $38 at KeyBanc Feb 29 6:19am ET Schrodinger price target lowered to $39 from $47 at Citi Feb 29 5:29am ET Schrodinger: A Neutral Rating with Revised Price Objective Amidst Growth Uncertainties Feb 29 4:15am ET Maintaining a Neutral Stance on Schrodinger Amidst Growth and Uncertainties Feb 29 2:51am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Schrodinger (SDGR), Editas Medicine (EDIT) and MacroGenics (MGNX) Feb 28 9:20pm ET Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Schrodinger (SDGR) Feb 28 5:51pm ET Schrodinger files automatic mixed securities shelf Feb 28 4:23pm ET Schrodinger sees FY24 software revenue growth up 6%-13% Feb 28 4:22pm ET Schrodinger reports Q4 EPS (32c), consensus (38c) Feb 26 9:06am ET Craig-Hallum Sticks to Their Buy Rating for Schrodinger (SDGR) Jan 26 5:51am ET Analysts Are Bullish on These Healthcare Stocks: Humana (HUM), Schrodinger (SDGR) Jan 26 5:36am ET Schrodinger initiated with an Outperform at TD Cowen Jan 19 8:54am ET Schrodinger price target lowered to $35 from $40 at Craig-Hallum Jan 09 5:16am ET Maintaining Hold: Balancing Schrodinger’s Strategic Shifts with Long-Term Drug Discovery Uncertainties Jan 08 10:07am ET Schrodinger announces expanded software agreement with Eli Lilly Jan 08 9:01am ET Analysts Conflicted on These Healthcare Names: Schrodinger (SDGR), Accelerate Diagnostics (AXDX) and Staar Surgical (STAA)

No recent press releases are available for SDGR

SDGR Financials

1-year income & revenue

Key terms

SDGR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SDGR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms